What is NDC 50090-1336?

50090-1336 is the product NDC for Aplisol (tuberculin purified protein derivative), Tuberculin purified protein derivative 5 [iU]/.1mL injection, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Aplisol (Tuberculin Purified Protein Derivative).

What is the active ingredient?

Tuberculin purified protein derivative.

A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Aplisol?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Aplisol NDC 50090-1336 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-1336Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-1336Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-1336-0	50090133600	1 VIAL in 1 CARTON (50090-1336-0) / 1 mL in 1 VIALMarketed from Nov 28, 2014

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aplisol
Generic name (nonproprietary): tuberculin purified protein derivative
Active ingredients: Tuberculin purified protein derivative — 5 [iU]/.1mL
Dosage form: Injection
Route: Intradermal
Labeler: A-S Medication SolutionsNDC labeler code 50090
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 103782
Marketing start: Apr 25, 2008
Listing expires: Dec 31, 2026
Other FDA classes: Bacterial (Chemical structure)Cell-mediated Immunity (Physiologic effect)
Identifiers: Product ID 50090-1336_d703ef2b-e51b-4d20-990b-3dd4161629a0SPL ID d703ef2b-e51b-4d20-990b-3dd4161629a0SPL set ID 9f025046-850f-46c1-bdfd-245032144307RxCUI 313532, 798408UNII I7L8FKN87J
Pharmacologic class: Skin Test Antigen; Tuberculosis Skin Test

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N450090133600 followed by a unit qualifier and the quantity

Package 50090-1336-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 9, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Tuberculin PPD is indicated as an aid in the detection of infection with Mycobacterium tuberculosis . The standard tuberculin test employs the intradermal (Mantoux) test using a 5 TU dose of tuberculin PPD. 7 The 0.1 mL test dose of Aplisol (tuberculin PPD, diluted) is equivalent to the 5 TU dose which has been clinically utilized and standardized with PPD-S. Tuberculin skin testing is not contraindicated for persons who have been vaccinated with BCG and the skin-test results of such persons are used to support or exclude the diagnosis of M. tuberculosis infections. 4 HIV infection is a strong risk factor for the development of TB disease in persons having TB infection.…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50090-1336

What is NDC 50090-1336?: 50090-1336 is the product NDC for Aplisol (tuberculin purified protein derivative), Tuberculin purified protein derivative 5 [iU]/.1mL injection, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Aplisol (Tuberculin Purified Protein Derivative).
What is the active ingredient?: Tuberculin purified protein derivative.
Who is the labeler?: A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Aplisol?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Aplisol (Tuberculin purified protein derivative) NDC 50090-1336